David McGibney M.D., Ph.D., FRCP,FFPM
Board Advisor,Vantia Ltd
|Age||Total Calculated Compensation||This person is connected to 42 board members in 3 different organizations across 6 different industries.|
See Board Relationships
Dr. David McGibney, M.D., Ph.D., FRCP,FFPM, serves as Chief Medical Officer and Head of Development at Heptares Therapeutics. Dr. McGibney serves as Scientific Advisor of Adalta Limited. He served as Pre-Clinical and Clinical Advisor at Cellzome AG. Dr. McGibney is an Independent Consultant in Pharmaceutical R & D and is a Consultant Pharmaceutical Physician. Previously, he was a Venture Partner at Imperial Innovations Group plc. Dr. McGibney was a clinical and drug ...
Epsilon HousePhone: 44 11 7916 7693
Southampton, Hampshire SO16 7NS
Fax: 44 23 8001 5945
Board Members Memberships*There is no Board Members Memberships data available.
University of Leeds Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.